Tissue Sectioning Global Market Report 2024

Tissue sectioning is a critical technique in histology and pathology used to prepare thin tissue slices for microscopic examination. This process is essential for studying the microscopic structure of tissues and understanding the pathological changes associated with diseases.

The main products of tissue sectioning include accessories and consumables, instruments, and services. Accessories and consumables are crucial items used during tissue sectioning to support and facilitate the process. Technologies such as automatic, manual, and semi-automatic methods are utilized to provide diagnostic and research applications for clinics, diagnostic laboratories, hospitals, and research centers.

The tissue sectioning market research report is one of a series of new reports that provides tissue sectioning market statistics, including the tissue sectioning industry global market size, regional shares, competitors with tissue sectioning market share, detailed tissue sectioning market segments, market trends, and opportunities, and any further data you may need to thrive in the tissue sectioning industry. These tissue sectioning market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue sectioning market size has grown strongly in recent years. It will grow from $0.69 billion in 2023 to $0.76 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth observed in the historic period can be attributed to several factors, including the increasing prevalence of chronic diseases, a growing aging population, rising investments in life sciences research, the expansion of biotechnology and pharmaceutical industries, government initiatives supporting research, a rising demand for companion diagnostics, increasing awareness about early disease detection, and growth in regenerative medicine.

The tissue sectioning market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The anticipated growth in the forecast period can be attributed to several factors, including the demand for personalized medicine, growth in biobanks, investments in research and development, increasing healthcare expenditure, growing awareness about early disease detection, emergence of digital pathology, rising demand for biomarker discovery, growing biopharmaceutical industry, and rising demand for point-of-care testing. Major trends expected during this period include advancements in automation technology, integration of AI and machine learning, digital pathology integration, adoption of 3D tissue sectioning techniques, development of high-throughput solutions, expansion of research applications, development of novel cutting techniques, advancements in imaging modalities, and adoption of cryosectioning techniques.

The tissue sectioning market is set to grow due to an increase in surgical procedures. Surgical procedures involve using instruments for diagnosing, treating, or repairing the body and are rising due to medical technology advancements, demographic shifts, and changes in healthcare practices. Tissue sectioning is crucial for surgeries as it provides precise, thin tissue slices for histological analysis, aiding in accurate diagnosis, treatment planning, and transplantation. For example, in 2022-23, there was an 18% increase in patients admitted for surgery from public hospital elective surgery waiting lists, as reported by the Australian Institute of Health and Welfare (AIHW), highlighting the growth in the tissue sectioning market driven by rising surgical procedures.

Leading companies in the tissue sectioning market are focusing on advanced technologies such as next-generation spatial gene expression technology to enhance tissue analysis and diagnostics. This technology allows detailed mapping of gene activity within tissue sections, offering insights into gene expression spatial organization and tissue architecture. For instance, 10x Genomics launched Visium HD in March 2024, enabling precise gene expression mapping in detailed anatomical structures from formalin-fixed, paraffin-embedded (FFPE) tissue sections. It provides high-resolution spatial gene expression data at single-cell scale resolution, allowing comprehensive characterization of FFPE tissue sections by measuring whole transcriptome spatial gene expression at single-cell resolution.

In May 2024, Bruker Corporation acquired NanoString Technologies to expand its product portfolio with advanced spatial gene expression tools, enhancing its ability to provide detailed insights into tissue morphology and gene expression. NanoString Technologies offers various platforms and technologies for analyzing gene and protein expression in tissue sections.

Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Labcorp Drug Development, Agilent Technologies Inc., Leica Biosystems Nussloch GmbH, Abcam Limited, Sakura Finetek USA Inc., Ted Pella Inc., Santa Cruz Biotechnology Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., LLS ROWIAK LaserLabSolutions GmbH, SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc.

North America was the largest region in the tissue sectioning market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue sectioning market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue sectioning market consists of revenues earned by entities by providing services such as tissue processing, microtomy, staining, and slide preparation. The market value includes the value of related goods sold by the service provider or included within the service offering. The tissue sectioning market also includes sales of microtome, paraffin dispenser, water bath, and section mounting equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.